Bynfezia Pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen Images
Generic Name: octreotide
This medication has been identified as Bynfezia Pen 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen and is used for Carcinoid Tumor, Acromegaly, and Vasoactive Intestinal Peptide Tumor. It belongs to the drug class somatostatin and somatostatin analogs and is not a controlled substance.
Images of medication
Bynfezia Pen
- Generic Name
- octreotide
- Strength
- 7000 mcg/2.8 mL (2500 mcg/mL) prefilled pen
- Availability
- Prescription only
- Drug Class
- Somatostatin and somatostatin analogs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 62756-0452
See also:
More about Bynfezia Pen (octreotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Patient resources
Other brands
Sandostatin, Sandostatin LAR Depot, Mycapssa
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.